Bacil Pharma share news, announcements and annual reports
BSE: 524516Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹18.40.
30 Oct: open ₹18.50, high ₹18.99, low ₹18.40
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹27 Cr3,172nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 1.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −0.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,126
Bacil Pharma has 542 announcements on record, routine notices left out; 5 in the 30 days to 30 Oct 2026, the latest on 14 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Bacil Pharma quarterly results
The board met on 14 Oct 2026 to consider quarterly results
Notice filed 5 Oct 2026
Bacil Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Bacil Pharma financials, year by year
Annual reports26
- Annual report, year to Mar 202631 Aug 2026
- Annual report, year to Mar 20255 Sep 2025
- Annual report, year to Mar 20244 Sep 2024
- Annual report, year to Mar 202324 Aug 2023
- Annual report, year to Mar 20227 Sep 2022
21 earlier reports
- Annual report, year to Mar 20213 Sep 2021
- Annual report, year to Mar 20208 Sep 2020
- Annual report, year to Mar 20196 Sep 2019
- Annual report, year to Mar 201830 Sep 2018
- Annual report, year to Mar 20175 Oct 2017
- Annual report, year to Mar 201620 Oct 2016
- Annual report, year to Mar 20158 Sep 2015
- Annual report, year to Mar 201410 Sep 2014
- Annual report, year to Mar 20136 Sep 2013
- Annual report, year to Mar 201228 Dec 2012
- Annual report, year to Mar 201129 Nov 2011
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 1998Filing day not known
Bacil Pharma share news and announcements
Newest first. Page 1 of 11.
Oct 2026
14 Oct · Results
8 Oct · Management
5 Oct · Board meeting
Meeting on 14 Oct 2026: quarterly results
Sep 2026
23 Sep · Meeting
Aug 2026
29 Aug · Corporate action
29 Aug · Board meeting
26 Aug · Board meeting
Meeting on 29 Aug 2026: annual general meeting25 Aug · Management
25 Aug · Board meeting
18 Aug · Board meeting
Meeting on 25 Aug 202612 Aug · Results
6 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
28 Jul · Announcement Under Regulation 30, LODR
18 Jul · Management
10 Jul · Management
9 Jul · Management
9 Jul · Announcement under Regulation 30 (LODR)-Raising of Funds
9 Jul · Board meeting
3 Jul · Board meeting
Meeting on 9 Jul 2026
Jun 2026
30 Jun · Management
29 Jun · Management
29 Jun · Management
26 Jun · Board meeting
23 Jun · Board meeting
Meeting on 26 Jun 2026: preferential issue of shares and rights issue
May 2026
22 May · Company Has Not Entered Any Related Party Transactions During The Half Year Ended 31St March, 2026.
22 May · Results
11 May · Board meeting
Meeting on 22 May 2026: audited results
Apr 2026
27 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Feb 2026
24 Feb · Legal
24 Feb · Legal
Exchange has sought clarification from Bacil Pharma Ltd on February 24, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 9 Oct 2026Board or managers changedup 2.31%+1.2 pts vs Nifty 500market median 0.0% · five sessions −9.3% (−11.9 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 20 Jul 2026Board or managers changeddown 5.00%−5.0 pts vs Nifty 500market median 0.0% · five sessions −22.6% (−20.8 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 10 Jul 2026Board or managers changedup 0.05%−1.1 pts vs Nifty 500market median 0.0% · five sessions −3.6% (−4.3 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 2 Dec 2025Board or managers changedup 0.05%+0.5 pts vs Nifty 500market median 0.0% · five sessions −1.6% (+0.1 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 18 Aug 2025Board or managers changed0.00%−1.3 pts vs Nifty 500market median 0.0% · five sessions −11.3% (−13.9 pts vs Nifty 500) · volume 2.8× usual · The announcement
- 11 Aug 2025Board or managers changeddown 0.21%+0.8 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−6.9 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 28 Jul 2025Board or managers changed–market median 0.0% · volume 3.8× usual · The announcement
- 27 Feb 2025Board or managers changeddown 0.98%−0.5 pts vs Nifty 500market median 0.0% · five sessions −8.6% (−7.8 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 27 Sep 2024Board or managers changedup 1.98%+2.0 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+14.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 2 Sep 2024Board or managers changedup 1.99%+1.9 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+11.4 pts vs Nifty 500) · volume 5.6× usual · The announcement
4 earlier announcements
- 29 Aug 2024Board or managers changedup 1.96%+1.9 pts vs Nifty 500market median 0.0% · five sessions +10.3% (+9.7 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 18 Sep 2023Board or managers changedup 4.86%+4.8 pts vs Nifty 500market median 0.0% · five sessions +27.1% (+28.9 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 22 Mar 2023Board or managers changeddown 1.01%−1.3 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−4.7 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 28 Apr 2020Board or managers changedup 4.76%+3.9 pts vs Nifty 500market median 0.0% · five sessions +25.9% (+27.0 pts vs Nifty 500) · volume 2.7× usual · The announcement